Order Kazusa clone(s) from :
Japan
||
Other countries |
Product ID | ORK01662 |
---|---|
Accession No | D87433 |
Description | stabilin 1 |
Clone name | ef02679 |
Vector information | |
cDNA sequence | DNA sequence (7909 bp) Predicted protein sequence (2589 aa) |
HaloTag ORF Clone |
FHC01662
|
Flexi ORF Clone | FXC01662 |
Source | |
Rouge ID |
mKIAA0246
by Kazusa Mouse cDNA Project
|
Note | We replaced ha04606, former representative clones for KIAA0246 with ef02679. (2002/5/10) |
N-terminal truncation | Coding interruption | |
---|---|---|
cloned DNA seq | Warning | No warning |
Length of 3'UTR | 137 bp |
---|---|
Genome contig ID | gi89161205f_52404411 |
PolyA signal sequence (None) |
+----*----+----*----+----*----+---- |
Flanking genome sequence (129140 - 129189) |
----+----*----+----*----+----*----+----*----+----* |
Ensembl ContigView (Add our DAS server as a DAS source)
Chr | f/r | start | end | exon | identity | class | |
---|---|---|---|---|---|---|---|
| 3 | f | 52504411 | 52533549 | 69 | 99.9 | Perfect prediction |
|
The numbers on the left and right sides of a black line in the graphical overview indicate the lengths (in amino acid residues) of the non-homologous N-terminal and C-terminal portions flanking the homologous region (indicated by the black line), respectively.Result of homology search against HUGE database (FASTA output, Multiple alignment)
|
The numbers on the left and right sides of a black line in the graphical overview indicate the lengths (in amino acid residues) of the non-homologous N-terminal and C-terminal portions flanking the homologous region (indicated by the black line), respectively.
Search method | interpro_ID | From | To | Entry | Definition |
---|---|---|---|---|---|
BlastProDom | IPR000538 | 2226 | 2273 | PD000918 | Link |
HMMPfam | IPR013111 | 131 | 166 | PF07974 | EGF |
IPR006209 | 255 | 289 | PF00008 | EGF-like | |
IPR000782 | 537 | 662 | PF02469 | Beta-Ig-H3/fasciclin | |
IPR006209 | 884 | 921 | PF00008 | EGF-like | |
IPR006209 | 970 | 1006 | PF00008 | EGF-like | |
IPR000782 | 1019 | 1139 | PF02469 | Beta-Ig-H3/fasciclin | |
IPR000782 | 1159 | 1232 | PF02469 | Beta-Ig-H3/fasciclin | |
IPR006209 | 1520 | 1557 | PF00008 | EGF-like | |
IPR000782 | 1625 | 1729 | PF02469 | Beta-Ig-H3/fasciclin | |
IPR000782 | 1755 | 1885 | PF02469 | Beta-Ig-H3/fasciclin | |
IPR002049 | 2011 | 2040 | PF00053 | EGF-like | |
IPR006209 | 2114 | 2149 | PF00008 | EGF-like | |
IPR006209 | 2155 | 2192 | PF00008 | EGF-like | |
IPR000538 | 2226 | 2319 | PF00193 | Link | |
HMMSmart | IPR006210 | 130 | 167 | SM00181 | EGF |
IPR002049 | 138 | 179 | SM00180 | EGF-like | |
IPR006210 | 178 | 212 | SM00181 | EGF | |
IPR002049 | 183 | 249 | SM00180 | EGF-like | |
IPR006210 | 217 | 250 | SM00181 | EGF | |
IPR006210 | 254 | 290 | SM00181 | EGF | |
IPR006210 | 294 | 337 | SM00181 | EGF | |
IPR006210 | 339 | 375 | SM00181 | EGF | |
IPR000782 | 417 | 517 | SM00554 | Beta-Ig-H3/fasciclin | |
IPR000782 | 561 | 663 | SM00554 | Beta-Ig-H3/fasciclin | |
IPR006210 | 747 | 787 | SM00181 | EGF | |
IPR006210 | 798 | 835 | SM00181 | EGF | |
IPR001881 | 840 | 879 | SM00179 | EGF-like calcium-binding | |
IPR006210 | 840 | 879 | SM00181 | EGF | |
IPR001881 | 882 | 922 | SM00179 | EGF-like calcium-binding | |
IPR006210 | 883 | 922 | SM00181 | EGF | |
IPR006210 | 926 | 965 | SM00181 | EGF | |
IPR006210 | 969 | 1007 | SM00181 | EGF | |
IPR000782 | 1041 | 1140 | SM00554 | Beta-Ig-H3/fasciclin | |
IPR000782 | 1183 | 1275 | SM00554 | Beta-Ig-H3/fasciclin | |
IPR006210 | 1350 | 1387 | SM00181 | EGF | |
IPR001881 | 1351 | 1387 | SM00179 | EGF-like calcium-binding | |
IPR002049 | 1359 | 1398 | SM00180 | EGF-like | |
IPR006210 | 1397 | 1431 | SM00181 | EGF | |
IPR006210 | 1438 | 1473 | SM00181 | EGF | |
IPR001881 | 1474 | 1515 | SM00179 | EGF-like calcium-binding | |
IPR006210 | 1477 | 1515 | SM00181 | EGF | |
IPR001881 | 1516 | 1558 | SM00179 | EGF-like calcium-binding | |
IPR006210 | 1519 | 1558 | SM00181 | EGF | |
IPR006210 | 1562 | 1601 | SM00181 | EGF | |
IPR000782 | 1634 | 1730 | SM00554 | Beta-Ig-H3/fasciclin | |
IPR000782 | 1781 | 1886 | SM00554 | Beta-Ig-H3/fasciclin | |
IPR001881 | 1986 | 2026 | SM00179 | EGF-like calcium-binding | |
IPR006210 | 1986 | 2026 | SM00181 | EGF | |
IPR002049 | 1987 | 2037 | SM00180 | EGF-like | |
IPR006210 | 2036 | 2070 | SM00181 | EGF | |
IPR006210 | 2078 | 2109 | SM00181 | EGF | |
IPR006210 | 2113 | 2150 | SM00181 | EGF | |
IPR006210 | 2154 | 2193 | SM00181 | EGF | |
IPR000538 | 2225 | 2320 | SM00445 | Link | |
IPR000782 | 2386 | 2481 | SM00554 | Beta-Ig-H3/fasciclin | |
ProfileScan | IPR000742 | 129 | 167 | PS50026 | EGF-like |
IPR000742 | 175 | 212 | PS50026 | EGF-like | |
IPR000742 | 214 | 248 | PS50026 | EGF-like | |
IPR000742 | 251 | 290 | PS50026 | EGF-like | |
IPR000782 | 375 | 513 | PS50213 | Beta-Ig-H3/fasciclin | |
IPR000782 | 525 | 660 | PS50213 | Beta-Ig-H3/fasciclin | |
IPR000742 | 747 | 787 | PS50026 | EGF-like | |
IPR000742 | 837 | 877 | PS50026 | EGF-like | |
IPR000742 | 880 | 922 | PS50026 | EGF-like | |
IPR000742 | 923 | 965 | PS50026 | EGF-like | |
IPR000742 | 966 | 1005 | PS50026 | EGF-like | |
IPR000782 | 1007 | 1137 | PS50213 | Beta-Ig-H3/fasciclin | |
IPR000782 | 1147 | 1272 | PS50213 | Beta-Ig-H3/fasciclin | |
IPR000742 | 1349 | 1387 | PS50026 | EGF-like | |
IPR000742 | 1394 | 1431 | PS50026 | EGF-like | |
IPR000742 | 1435 | 1473 | PS50026 | EGF-like | |
IPR000742 | 1474 | 1515 | PS50026 | EGF-like | |
IPR000742 | 1516 | 1558 | PS50026 | EGF-like | |
IPR000742 | 1559 | 1601 | PS50026 | EGF-like | |
IPR000782 | 1601 | 1727 | PS50213 | Beta-Ig-H3/fasciclin | |
IPR000782 | 1743 | 1883 | PS50213 | Beta-Ig-H3/fasciclin | |
IPR000742 | 1988 | 2026 | PS50026 | EGF-like | |
IPR000742 | 2033 | 2070 | PS50026 | EGF-like | |
IPR000742 | 2075 | 2109 | PS50026 | EGF-like | |
IPR000742 | 2110 | 2150 | PS50026 | EGF-like | |
IPR000742 | 2151 | 2193 | PS50026 | EGF-like | |
IPR000538 | 2227 | 2320 | PS50963 | Link | |
IPR000782 | 2341 | 2478 | PS50213 | Beta-Ig-H3/fasciclin | |
ScanRegExp | IPR013032 | 155 | 166 | PS00022 | EGF-like region |
IPR013032 | 200 | 211 | PS00022 | EGF-like region | |
IPR013032 | 200 | 211 | PS01186 | EGF-like region | |
IPR013032 | 236 | 249 | PS01186 | EGF-like region | |
IPR001128 | 744 | 753 | PS00086 | Cytochrome P450 | |
IPR013032 | 775 | 786 | PS00022 | EGF-like region | |
IPR013032 | 865 | 878 | PS01186 | EGF-like region | |
IPR013032 | 908 | 921 | PS01186 | EGF-like region | |
IPR001128 | 914 | 923 | PS00086 | Cytochrome P450 | |
IPR013032 | 951 | 964 | PS01186 | EGF-like region | |
IPR013032 | 993 | 1006 | PS01186 | EGF-like region | |
IPR013032 | 1375 | 1386 | PS00022 | EGF-like region | |
IPR013032 | 1375 | 1389 | PS01186 | EGF-like region | |
IPR002049 | 1375 | 1409 | PS01248 | EGF-like | |
IPR013032 | 1419 | 1430 | PS00022 | EGF-like region | |
IPR013032 | 1419 | 1430 | PS01186 | EGF-like region | |
IPR013032 | 1459 | 1472 | PS01186 | EGF-like region | |
IPR013032 | 1501 | 1514 | PS01186 | EGF-like region | |
IPR013032 | 1543 | 1557 | PS01186 | EGF-like region | |
IPR013032 | 2014 | 2025 | PS00022 | EGF-like region | |
IPR013032 | 2014 | 2028 | PS01186 | EGF-like region | |
IPR002049 | 2014 | 2048 | PS01248 | EGF-like | |
IPR013032 | 2058 | 2069 | PS00022 | EGF-like region | |
IPR013032 | 2058 | 2069 | PS01186 | EGF-like region | |
IPR013032 | 2095 | 2108 | PS01186 | EGF-like region | |
IPR013032 | 2179 | 2192 | PS01186 | EGF-like region | |
IPR000538 | 2249 | 2294 | PS01241 | Link | |
IPR013032 | 2326 | 2340 | PS01186 | EGF-like region |
Method | No. | N terminal | transmembrane region | C terminal | type | length | SOSUI2 | 1 | 21 | AGPRGLLPLCLLAFCLAGFSFVR | 43 | PRIMARY | 23 | 2 | 2452 | GTVVVSRIIVWDIMAFNGIIHAL | 2474 | SECONDARY | 23 | 3 | 2496 | AAGVGAVLAAGALLGLVAGALYL | 2518 | PRIMARY | 23 |
---|
Panel name | Genebridge 4 |
---|---|
Primer_f | TGATGCTGATGACGACTTCTC |
Primer_r | CAATAAAAGTGGTCTCCTCCC |
PCR product length | 216 bp |
PCR conditions | 95 °C15 sec64 °C60 sec30 cycles |